Eco Animal Health Group PLC Director/PDMR Shareholding
2024年8月30日 - 11:07PM
RNS Regulatory News
RNS Number : 3786C
Eco Animal Health Group PLC
30 August 2024
30 August
2024
ECO Animal Health Group
plc
("ECO" or
the "Company")
Director/PDMR Dealings
ECO Animal Health Group plc, a leader in the
development, registration and marketing of pharmaceutical products
for global animal health markets, has been notified that on 30
August 2024, David Hallas, Chief Executive Officer,
purchased 18,181 ordinary shares of 5 pence each ("Ordinary
Shares") at a price of 110 pence per share.
Following this transaction, David Hallas' total
interest in the Company is 109,334 Ordinary Shares, representing
approximately 0.16 per cent. of the Company's issued share
capital.
Details of the transactions can be
found in the Notification of Dealing Form below.
For further
information please contact:
ECO Animal
Health Group plc
David Hallas (CEO)
Christopher Wilks (CFO)
|
020 8447 8899
|
Singer Capital
Markets (Nominated Adviser & Joint Broker)
Phil Davies
Sam Butcher
|
020 7496 3000
|
Investec
(Joint Broker)
Gary Clarence
Lydia Zychowska
|
020 7597 5970
|
Equity
Development
Hannah Crowe
Matt Evans
|
020 7065 2692
|
ICR Consilium
(Financial PR)
Mary-Jane Elliott
Jessica Hodgson
|
020 3709 5700
ecoanimalhealth@consilium-comms.com
|
About ECO
Animal Health
ECO Animal Health is a world leader in animal
health, developing and marketing branded veterinary pharmaceuticals
globally, with expertise in antibiotics and vaccines for pigs and
poultry. We have a maturing proprietary R&D
pipeline.
Headquartered in the UK, with global offices
including R&D and manufacturing, we have marketing
authorisations in over 70 countries and employ over 200 people
worldwide.
Our lead product, Aivlosin® is a proprietary,
patented medication which is effective against both respiratory and
intestinal diseases in pigs and poultry.
Click here for more information: https://ecoanimalhealth.com
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
a)
|
Name
|
David Hallas
|
2
|
Reason for the notification
|
a)
|
Position/status
|
Chief Executive Officer
|
b)
|
Initial notification
/Amendment
|
Initial notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a)
|
Name
|
ECO Animal Health Group plc
|
b)
|
LEI
|
2138009XN9DJ3YP70B55
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
a)
|
Description of the financial
instrument, type of instrument
|
Ordinary shares of 5 pence
each
|
|
|
Identification code
|
GB0032036807
|
|
|
b)
|
Nature of the transaction
|
Purchase of Ordinary Shares
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
110 pence
|
18,181
|
|
|
|
|
|
|
d)
|
Aggregated information
|
N/A - Single transaction
|
|
|
- Aggregated volume
|
|
|
|
- Price
|
|
|
|
e)
|
Date of the transaction
|
30 August 2024
|
f)
|
Place of the transaction
|
London Stock Exchange, AIM
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHBSGDILGXDGSG
Eco Animal Health (LSE:EAH)
過去 株価チャート
から 11 2024 まで 12 2024
Eco Animal Health (LSE:EAH)
過去 株価チャート
から 12 2023 まで 12 2024